Inventor

CASTELHANO ARLINDO L

US34 patents

⚠️ This page may combine multiple inventors who share the name “CASTELHANO ARLINDO L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CASTELHANO ARLINDO L

OSI PHARM INC

Compounds specific to adenosine A1 receptors and uses thereof

Compounds specific to adenosine A1 receptors and uses thereof

Compounds specific to adenosine A1 and A3 receptors and uses thereof

Compounds specific to adenosine A1 receptor and uses thereof

Pyrrolo[2,3d]pyrimidine compositions and their use

Compounds specific to adenosine A3 receptor and uses thereof

Compounds specific to adenosine A3 receptor and uses thereof

4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof

N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitors

4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use

Compounds specific to adenosine A3 receptor and uses thereof

N-substituted benzimidazolyl c-Kit inhibitors

Conformationallly constrained peptidomimetics as β-turn templates and modulators of SH3 domains

Solid phase synthesis of heterocycles

Compounds specific to adenosine A, receptors and uses thereof

Preparation of pyridone-based phosphotyrosine mimetics and uses thereof

N3-substituted imidazopyridine c-Kit inhibitors

Naphthylene derivatives as cytochrome P450 inhibitors

N-substituted imidazopyridine c-Kit inhibitors

(Arylamidoaryl)squaramide compounds

AGOURON PHARMA

Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use

Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use

Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their pharmaceutical uses

Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses

Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use

SYNTEX INC

Transglutaminase inhibitors

3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitors

Transglutaminase inhibitors

α-allenic-α-amino acids as enzyme inhibitors

γ-allenyl-γ-aminobutyric acids

THE WISTAR INST

EBNA1 inhibitor crystalline forms, and methods of preparing and using same

EBNA1 inhibitor crystalline forms, and methods of preparing and using same

OSI PHARM

Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds

CASTELHANO ARLINDO L

mTOR inhibitor salt forms